In our sequencing study cohort, we analyzed the relationship between ARID1A mutations and the prognosis of glioma patients and found that ARID1A mutations were negatively correlated with the prognosis of glioma patients (p = 0.0217) (Figure 2C). This evidence concerns the gene ARID1A and glioma.